Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens
International Journal of Molecular Sciences · 04.02.2023 · 24 (4) · 3092
DOI: 10.3390/ijms24043092 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.02.2023. Verfasst von Rosa Bellavita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Medicine, University of Naples 'Federico II', Via Domenico Montesano 49, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic lung infections in cystic fibrosis (CF) patients are triggered by multidrug-resistant bacteria such as Pseudomonas aeruginosa, Achromobacter xylosoxidans, and Stenotrophomonas maltophilia. The CF airways are considered ideal sites for the colonization and growth of bacteria and fungi that favor the formation of mixed biofilms that are difficult to treat. The inefficacy of traditional antibiotics reinforces the need to find novel molecules able to fight these chronic infections. Antimicrobial peptides (AMPs) represent a promising alternative for their antimicrobial, anti-inflammatory, and immunomodulatory activities. We developed a more serum-stable version of the peptide WMR (WMR-4) and investigated its ability to inhibit and eradicate C. albicans, S. maltophilia, and A. xylosoxidans biofilms in both in vitro and in vivo studies. Our results suggest that the peptide is able better to inhibit than to eradicate both mono and dual-species biofilms, which is further confirmed by the downregulation of some genes involved in biofilm formation or in quorum-sensing signaling. Biophysical data help to elucidate its mode of action, showing a strong interaction of WMR-4 with lipopolysaccharide (LPS) and its insertion in liposomes mimicking Gram-negative and Candida membranes. Our results support the promising therapeutic application of AMPs in the treatment of mono- and dual-species biofilms during chronic infections in CF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, School of Medicine, University of Naples 'Federico II', Via Domenico Montesano 49, 80131 Naples, Italy.
- Department of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.
- Department of Agricultural Sciences, University of Naples 'Federico II', Via dell' Università 100, 80055 Portici, Italy.
ORCID-Profile: Rosa Bellavita, Angela Maione, Stefania Galdiero, Emilia Galdiero, Annarita Falanga
Zitieren
APA
Bellavita, R., Maione, A., Braccia, S., Sinoca, M., Galdiero, S., Galdiero, E., & Falanga, A. (2023). Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens. International Journal of Molecular Sciences, 24(4), 3092. https://doi.org/10.3390/ijms24043092
Vancouver
Bellavita R, Maione A, Braccia S, Sinoca M, Galdiero S, Galdiero E, et al. Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens. International Journal of Molecular Sciences. 2023;24(4):3092. doi:10.3390/ijms24043092
BibTeX
@article{Bellavita2023,
author = {Bellavita, Rosa and Maione, Angela and Braccia, Simone and Sinoca, Marica and Galdiero, Stefania and Galdiero, Emilia and Falanga, Annarita},
title = {Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3092},
doi = {10.3390/ijms24043092}
}
EUVIMED